Swimming training-based PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Swimming training inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene, 16/May/2017, 11.41 pm

Laminar shear force-based therapy for TIIDM and Metabolic defects: Laminar shear force increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 15/May/2017, 11.59 pm
May 15, 2017
Amino acid-derived therapy for Inflammatory bowel disease: L-Leucine, the branched chain amino acid, promotes NFKB-p50/p65 dimer formation, induces inflammatory gene expression downstream of RelA/p65, inhibits colonic pathogenesis, and stalls the progression of inflammatory bowel disease and colitis via down regulation of its target gene, 16/May/2017, 11.59 pm
May 16, 2017
Show all

Introduction:What they say:

A recent study from Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Unit 108, 1515 Holcombe Boulevard, Houston, TX 77030, USA shows that “Deubiquitination and Stabilization of PD-L1 by CSN5.” This study was published in the 12 December 2016 issue of Cancer cell (one of the best journals in Cancer Science with an impact factor of 23.523) by Prof Mien-Chie Hung, Lim SO and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Swimming training-based PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Swimming training inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene


What is known?

It has recently been shown that blocking cell surface receptor PD-1 with antibodies one could make tumors shrink. This work, relating to Cancer immunotherapy, has been chosen as Science’s breakthrough of the year recently.


From Research Findings to Therapeutic opportunity

Swimming training, by decreasing the expression of its target gene, it may  diminish the expression of PD-L1 (fig. 1). Thereby, it may: (i) inhibit inflammatory TNFα signaling; (ii) decrease the number of tumor-infiltrating lymphocytes and macrophages; (iii) increase T-cell anti-tumor immunity; (iv) decrease tumor burden; and (v) increase survival of patients with breast cancer (fig. 1).  

Figure 1. Mechanistic insight into how Swimming training enhances the efficacy of cancer immunotherapy. Swimming training , by decreasing the expression of PD-L1 in cancer cells, it augments T-cell mediated anti-tumor immunity

Thus,  swimming training may be advised for cancer patients to (i) inhibit the progression of tumors; and (ii) enhance the efficacy of Cancer immunotherapy. Together,  oncologists may consider recommending their cancer patients to undergo swimming therapy.

price-50


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Amount: $50#

Undisclosed mechanistic information: How Swimming training inhibits the expression of PD-L1 and augments anti-tumor immunity

For purchase and payment details, you may reach us at admin@genomediscovery.org

# Research cooperation


References

Citation: Boominathan, L., Swimming training-based PD-L1 pathway blockade enhances the efficacy of Cancer immunotherapy: Swimming training inhibits the expression of PD-L1, inhibits inflammatory signalling and the number of tumor-infiltrating lymphocytes and macrophages, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene, 16/May/2017, 11.41 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or http://newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.